Quick Answer
SELLAS Life Sciences Group, Inc. reported Long-Term Debt of $0.00 for fiscal year 2018.
SELLAS Life Sciences Group, Inc. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2018 | $0.00 | -100.0% |
| 2017 | $2.61M | — |
| 2015 | $0.00 | -100.0% |
| 2014 | $4.49M | -42.0% |
| 2013 | $7.74M | — |
| 2012 | $0.00 | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2018 | $0.00 | — | — |
| June 30, 2018 | $0.00 | — | -100.0% |
| March 31, 2018 | $1.15M | — | -56.0% |
| December 31, 2017 | $2.61M | — | +71.1% |
| September 30, 2015 | $1.53M | -70.1% | -40.1% |
| June 30, 2015 | $2.55M | -57.6% | -28.0% |
| March 31, 2015 | $3.53M | -48.7% | -21.3% |
| December 31, 2014 | $4.49M | -42.0% | -11.9% |
- SELLAS Life Sciences Group, Inc. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- The most recent figure is from SELLAS Life Sciences Group, Inc.’s fiscal year 2018 report (Form 10-K), filed with the SEC on March 22, 2019.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: